Compile Data Set for Download or QSAR
Report error Found 620 Enz. Inhib. hit(s) with Target = '5'-AMP-activated protein kinase catalytic subunit alpha-1'
Target5'-AMP-activated protein kinase catalytic subunit alpha-1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM200907(US9540364, example 1)
Affinity DataEC50:  216nMpH: 7.3Assay Description:The in vitro AMPK activation assay is performed in a volume of 30 μl in a 384-well plate. Enzyme reactions were assembled in the microtiter plat...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

Target5'-AMP-activated protein kinase catalytic subunit alpha-1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM200991(US9540364, example 2)
Affinity DataEC50:  4.29E+3nMpH: 7.3Assay Description:The in vitro AMPK activation assay is performed in a volume of 30 μl in a 384-well plate. Enzyme reactions were assembled in the microtiter plat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

Target5'-AMP-activated protein kinase catalytic subunit alpha-1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM200992(US9540364, example 3)
Affinity DataEC50:  8nMpH: 7.3Assay Description:The in vitro AMPK activation assay is performed in a volume of 30 μl in a 384-well plate. Enzyme reactions were assembled in the microtiter plat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

Target5'-AMP-activated protein kinase catalytic subunit alpha-1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM200993(US9540364, example 4)
Affinity DataEC50:  104nMpH: 7.3Assay Description:The in vitro AMPK activation assay is performed in a volume of 30 μl in a 384-well plate. Enzyme reactions were assembled in the microtiter plat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

Target5'-AMP-activated protein kinase catalytic subunit alpha-1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM200994(US9540364, example 5)
Affinity DataEC50:  209nMpH: 7.3Assay Description:The in vitro AMPK activation assay is performed in a volume of 30 μl in a 384-well plate. Enzyme reactions were assembled in the microtiter plat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

Target5'-AMP-activated protein kinase catalytic subunit alpha-1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM200995(US9540364, example 7)
Affinity DataEC50:  8nMpH: 7.3Assay Description:The in vitro AMPK activation assay is performed in a volume of 30 μl in a 384-well plate. Enzyme reactions were assembled in the microtiter plat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

Target5'-AMP-activated protein kinase catalytic subunit alpha-1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM200996(US9540364, example 8)
Affinity DataEC50:  5nMpH: 7.3Assay Description:The in vitro AMPK activation assay is performed in a volume of 30 μl in a 384-well plate. Enzyme reactions were assembled in the microtiter plat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

Target5'-AMP-activated protein kinase catalytic subunit alpha-1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM200997(US9540364, example 9)
Affinity DataEC50:  33nMpH: 7.3Assay Description:The in vitro AMPK activation assay is performed in a volume of 30 μl in a 384-well plate. Enzyme reactions were assembled in the microtiter plat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

Target5'-AMP-activated protein kinase catalytic subunit alpha-1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM200998(US9540364, example 10)
Affinity DataEC50:  34nMpH: 7.3Assay Description:The in vitro AMPK activation assay is performed in a volume of 30 μl in a 384-well plate. Enzyme reactions were assembled in the microtiter plat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

Target5'-AMP-activated protein kinase catalytic subunit alpha-1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM200999(US9540364, example 12)
Affinity DataEC50:  76nMpH: 7.3Assay Description:The in vitro AMPK activation assay is performed in a volume of 30 μl in a 384-well plate. Enzyme reactions were assembled in the microtiter plat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

Target5'-AMP-activated protein kinase catalytic subunit alpha-1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM201001(US9540364, example 13)
Affinity DataEC50:  5nMpH: 7.3Assay Description:The in vitro AMPK activation assay is performed in a volume of 30 μl in a 384-well plate. Enzyme reactions were assembled in the microtiter plat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

Target5'-AMP-activated protein kinase catalytic subunit alpha-1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM201004(US9540364, example 14)
Affinity DataEC50:  4nMpH: 7.3Assay Description:The in vitro AMPK activation assay is performed in a volume of 30 μl in a 384-well plate. Enzyme reactions were assembled in the microtiter plat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

Target5'-AMP-activated protein kinase catalytic subunit alpha-1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM201005(US9540364, example 15)
Affinity DataEC50:  3nMpH: 7.3Assay Description:The in vitro AMPK activation assay is performed in a volume of 30 μl in a 384-well plate. Enzyme reactions were assembled in the microtiter plat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

Target5'-AMP-activated protein kinase catalytic subunit alpha-1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM201006(US9540364, example 16)
Affinity DataEC50:  6nMpH: 7.3Assay Description:The in vitro AMPK activation assay is performed in a volume of 30 μl in a 384-well plate. Enzyme reactions were assembled in the microtiter plat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

Target5'-AMP-activated protein kinase catalytic subunit alpha-1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM201007(US9540364, example 17)
Affinity DataEC50:  20nMpH: 7.3Assay Description:The in vitro AMPK activation assay is performed in a volume of 30 μl in a 384-well plate. Enzyme reactions were assembled in the microtiter plat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

Target5'-AMP-activated protein kinase catalytic subunit alpha-1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM201008(US9540364, example 18)
Affinity DataEC50:  34nMpH: 7.3Assay Description:The in vitro AMPK activation assay is performed in a volume of 30 μl in a 384-well plate. Enzyme reactions were assembled in the microtiter plat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

Target5'-AMP-activated protein kinase catalytic subunit alpha-1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM201009(US9540364, example 19)
Affinity DataEC50:  67nMpH: 7.3Assay Description:The in vitro AMPK activation assay is performed in a volume of 30 μl in a 384-well plate. Enzyme reactions were assembled in the microtiter plat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

Target5'-AMP-activated protein kinase catalytic subunit alpha-1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM201010(US9540364, example 20)
Affinity DataEC50:  50nMpH: 7.3Assay Description:The in vitro AMPK activation assay is performed in a volume of 30 μl in a 384-well plate. Enzyme reactions were assembled in the microtiter plat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

Target5'-AMP-activated protein kinase catalytic subunit alpha-1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM201011(US9540364, example 21)
Affinity DataEC50:  38nMpH: 7.3Assay Description:The in vitro AMPK activation assay is performed in a volume of 30 μl in a 384-well plate. Enzyme reactions were assembled in the microtiter plat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

LigandPNGBDBM246890((3R,3aR,6R,6aR)-6-(6-Chloro-5-iodo-3-(2-trimethyls...)
Affinity DataEC50:  284nMpH: 7.0 T: 2°CAssay Description:The test compounds were dissolved in 100% DMSO at a concentration of 10 mM and in a first step diluted in DMSO to a concentration of 5 mM, followed b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

LigandPNGBDBM246895(({4-[4-(2-{[(3R,3aR,6R,6aR)-6-Hydroxy-hexahydrofur...)
Affinity DataEC50:  115nMpH: 7.0 T: 2°CAssay Description:The test compounds were dissolved in 100% DMSO at a concentration of 10 mM and in a first step diluted in DMSO to a concentration of 5 mM, followed b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

LigandPNGBDBM246992(({4-[4-(2-{[(3R,3aR,6R,6aR)-6-Hydroxy-hexahydrofur...)
Affinity DataEC50:  302nMpH: 7.0 T: 2°CAssay Description:The test compounds were dissolved in 100% DMSO at a concentration of 10 mM and in a first step diluted in DMSO to a concentration of 5 mM, followed b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

LigandPNGBDBM246993(({4-[4-(2-{[(3R,3aR,6R,6aR)-6-Hydroxy-hexahydrofur...)
Affinity DataEC50:  3.56E+3nMpH: 7.0 T: 2°CAssay Description:The test compounds were dissolved in 100% DMSO at a concentration of 10 mM and in a first step diluted in DMSO to a concentration of 5 mM, followed b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

LigandPNGBDBM246994(({4-[4-(2-{[(3R,3aR,6R,6aR)-6-Hydroxy-hexahydrofur...)
Affinity DataEC50:  60nMpH: 7.0 T: 2°CAssay Description:The test compounds were dissolved in 100% DMSO at a concentration of 10 mM and in a first step diluted in DMSO to a concentration of 5 mM, followed b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

LigandPNGBDBM246995(({4-[4-(2-{[(3R,3aR,6R,6aR)-6-Hydroxy-hexahydrofur...)
Affinity DataEC50:  450nMpH: 7.0 T: 2°CAssay Description:The test compounds were dissolved in 100% DMSO at a concentration of 10 mM and in a first step diluted in DMSO to a concentration of 5 mM, followed b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

LigandPNGBDBM246996(({4-[4-(2-{[(3R,3aR,6R,6aR)-6-Hydroxy-hexahydrofur...)
Affinity DataEC50:  125nMpH: 7.0 T: 2°CAssay Description:The test compounds were dissolved in 100% DMSO at a concentration of 10 mM and in a first step diluted in DMSO to a concentration of 5 mM, followed b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

LigandPNGBDBM246997(({4-[4-(2-{[(3R,3aR,6R,6aR)-6-Hydroxy-hexahydrofur...)
Affinity DataEC50:  255nMpH: 7.0 T: 2°CAssay Description:The test compounds were dissolved in 100% DMSO at a concentration of 10 mM and in a first step diluted in DMSO to a concentration of 5 mM, followed b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

LigandPNGBDBM246998(({4-[4-(2-{[(3R,3aR,6R,6aR)-6-Hydroxy-hexahydrofur...)
Affinity DataEC50:  282nMpH: 7.0 T: 2°CAssay Description:The test compounds were dissolved in 100% DMSO at a concentration of 10 mM and in a first step diluted in DMSO to a concentration of 5 mM, followed b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

LigandPNGBDBM246999(({6-[4-(2-{[(3R,3aR,6R,6aR)-6-Hydroxy-hexahydrofur...)
Affinity DataEC50:  193nMpH: 7.0 T: 2°CAssay Description:The test compounds were dissolved in 100% DMSO at a concentration of 10 mM and in a first step diluted in DMSO to a concentration of 5 mM, followed b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

LigandPNGBDBM247000(({4-[5-(2-{[(3R,3aR,6R,6aR)-6-Hydroxy-hexahydrofur...)
Affinity DataEC50:  1.20E+3nMpH: 7.0 T: 2°CAssay Description:The test compounds were dissolved in 100% DMSO at a concentration of 10 mM and in a first step diluted in DMSO to a concentration of 5 mM, followed b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

LigandPNGBDBM247001(({4-[5-(2-{[(3R,3aR,6R,6aR)-6-Hydroxy-hexahydrofur...)
Affinity DataEC50:  109nMpH: 7.0 T: 2°CAssay Description:The test compounds were dissolved in 100% DMSO at a concentration of 10 mM and in a first step diluted in DMSO to a concentration of 5 mM, followed b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

LigandPNGBDBM247002(({4-[4-(2-{[(3R,3aR,6R,6aR)-6-Hydroxy-hexahydrofur...)
Affinity DataEC50:  71nMpH: 7.0 T: 2°CAssay Description:The test compounds were dissolved in 100% DMSO at a concentration of 10 mM and in a first step diluted in DMSO to a concentration of 5 mM, followed b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

LigandPNGBDBM247003({4-[4-(2-{[(3R,3aR,6R,6aR)-6-Hydroxy-hexahydrofuro...)
Affinity DataEC50:  68nMpH: 7.0 T: 2°CAssay Description:The test compounds were dissolved in 100% DMSO at a concentration of 10 mM and in a first step diluted in DMSO to a concentration of 5 mM, followed b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

LigandPNGBDBM247004(({4-[5-(2-{[(3R,3aR,6R,6aR)-6-Hydroxy-hexahydrofur...)
Affinity DataEC50:  344nMpH: 7.0 T: 2°CAssay Description:The test compounds were dissolved in 100% DMSO at a concentration of 10 mM and in a first step diluted in DMSO to a concentration of 5 mM, followed b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

LigandPNGBDBM247005(({4-[4-(2-{[(3R,3aR,6R,6aR)-6-Hydroxy-hexahydrofur...)
Affinity DataEC50:  74nMpH: 7.0 T: 2°CAssay Description:The test compounds were dissolved in 100% DMSO at a concentration of 10 mM and in a first step diluted in DMSO to a concentration of 5 mM, followed b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

LigandPNGBDBM247006(US10053471, 17 | ({4-[4-(2-{[(3R,3aR,6R,6aR)-6-Hyd...)
Affinity DataEC50:  84nMpH: 7.0 T: 2°CAssay Description:The test compounds were dissolved in 100% DMSO at a concentration of 10 mM and in a first step diluted in DMSO to a concentration of 5 mM, followed b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

Target5'-AMP-activated protein kinase catalytic subunit alpha-1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM31085(cid_11409972 | 1-[4-[(4-ethylpiperazin-1-yl)methyl...)
Affinity DataKd:  1.40E+3nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/22/2011
Entry Details
PCBioAssay
Target5'-AMP-activated protein kinase catalytic subunit alpha-1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM25118(4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-...)
Affinity DataKd:  520nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/22/2011
Entry Details
PCBioAssay
Target5'-AMP-activated protein kinase catalytic subunit alpha-1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM31088(1-methyl-5-[[2-[5-(trifluoromethyl)-1H-imidazol-2-...)
Affinity DataKd:  4.50E+3nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/22/2011
Entry Details
PCBioAssay
Target5'-AMP-activated protein kinase catalytic subunit alpha-1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM6866(1-Acyl-1H-[1,2,4]triazole-3,5-diamine Analogue 3b ...)
Affinity DataKd:  1.70E+3nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/22/2011
Entry Details
PCBioAssay
Target5'-AMP-activated protein kinase catalytic subunit alpha-1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM31094(PKC-412 | cid_24202429)
Affinity DataKd:  180nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/22/2011
Entry Details
PCBioAssay
Target5'-AMP-activated protein kinase catalytic subunit alpha-1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM31095(5-[(Z)-(5-fluoranyl-2-oxidanylidene-1H-indol-3-yli...)
Affinity DataKd:  100nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/22/2011
Entry Details
PCBioAssay
Target5'-AMP-activated protein kinase catalytic subunit alpha-1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM31096(CHEMBL290084 | Staurosporine | cid_451705 | US2024...)
Affinity DataKd:  3.70nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/22/2011
Entry Details
PCBioAssay
Target5'-AMP-activated protein kinase catalytic subunit alpha-1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM4814(SUNITINIB MALATE | CHEMBL535 | N-[2-(diethylamino)...)
Affinity DataKd:  19nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/22/2011
Entry Details
PCBioAssay
Target5'-AMP-activated protein kinase catalytic subunit alpha-1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM13534(VX680 | N-[4-[[4-(4-methylpiperazino)-6-[(5-methyl...)
Affinity DataKd:  1.10E+3nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/22/2011
Entry Details
PCBioAssay
Target5'-AMP-activated protein kinase catalytic subunit alpha-1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM192505(US9187477, 1)
Affinity DataEC50:  1.20nMpH: 7.0Assay Description:In the 384-well plates 1.25 ul of test compound in assay buffer (20 mM HEPES pH 7.0, 0.025% BSA, 15 mM MgCl2, 0.01% Brij) was mixed with 1.25 ul of A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/12/2016
Entry Details
US Patent

Target5'-AMP-activated protein kinase catalytic subunit alpha-1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM192506(US9187477, 2)
Affinity DataEC50:  32nMpH: 7.0Assay Description:In the 384-well plates 1.25 ul of test compound in assay buffer (20 mM HEPES pH 7.0, 0.025% BSA, 15 mM MgCl2, 0.01% Brij) was mixed with 1.25 ul of A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/12/2016
Entry Details
US Patent

Target5'-AMP-activated protein kinase catalytic subunit alpha-1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM192507(US9187477, 3)
Affinity DataEC50:  108nMpH: 7.0Assay Description:In the 384-well plates 1.25 ul of test compound in assay buffer (20 mM HEPES pH 7.0, 0.025% BSA, 15 mM MgCl2, 0.01% Brij) was mixed with 1.25 ul of A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/12/2016
Entry Details
US Patent

Target5'-AMP-activated protein kinase catalytic subunit alpha-1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM192508(US9187477, 16 | US9187477, 4)
Affinity DataEC50:  12nMpH: 7.0Assay Description:In the 384-well plates 1.25 ul of test compound in assay buffer (20 mM HEPES pH 7.0, 0.025% BSA, 15 mM MgCl2, 0.01% Brij) was mixed with 1.25 ul of A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/12/2016
Entry Details
US Patent

Target5'-AMP-activated protein kinase catalytic subunit alpha-1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM192509(US9187477, 5)
Affinity DataEC50:  119nMpH: 7.0Assay Description:In the 384-well plates 1.25 ul of test compound in assay buffer (20 mM HEPES pH 7.0, 0.025% BSA, 15 mM MgCl2, 0.01% Brij) was mixed with 1.25 ul of A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/12/2016
Entry Details
US Patent

Displayed 1 to 50 (of 620 total ) | Next | Last >>
Jump to: